AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For ScanSource, the big picture you need to believe in is a disciplined, margin-focused distributor that can keep deepening its role in higher-value networking, security and cloud ecosystems, rather than competing on volume alone. The expanded HPE partnership, now folded into Launch Point, looks relevant to that story because it could bring more AI-native networking and SD-WAN business into ScanSource’s orbit and reinforce its solutions-led push across verticals. In the short term, key catalysts still sit in execution: converting these new HPE routes-to-market into tangible sales, integrating prior acquisitions to support recurring revenue, and continuing to balance buybacks with investment. The main risks also sharpen a bit with this news, as ScanSource leans harder on a few major vendors while operating in a low-margin, competitive sector and carrying fresh credit facilities.
However, a bigger vendor concentration risk is emerging that investors should not ignore. ScanSource's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.Explore another fair value estimate on ScanSource - why the stock might be worth as much as $46.44!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com